← Leaderboards
E Wesley Ely
Vanderbilt University Medical Center
$22,934,169
Attributed
$43,012,378
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,012,378 · 7
VA$0 · 1
By mechanism
R01$40,511,464 · 4
R42$1,812,577 · 1
K23$620,855 · 1
U54$67,482 · 1
I01$0 · 1
Top collaborators
- Mayur B Patel13 shared
- Angela L. Jefferson7 shared
- Priscilla Y. Hsue2 shared
- Vincent Charles Marconi2 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Dario J Englot$4,274,735
- Victoria L Morgan$7,532,616
- Macrae F Linton$20,130,632
- Heidi A B Smith$2,104,103
- Jin Ho Han$4,859,012
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposImpaired CognitionIntensive Care UnitsBrainMedicalDementiaHospitalsCognitiveEnrollmentRisk FactorsIncidenceCessation Of LifeFutureCritical IllnessSurvivorsAcuteSurgical Intensive CareFunctional DisorderCaringDeliriumAffectFollow-UpOperative Surgical ProceduresComorbidity
Grant awards (37)
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD$6,107,805
R01 · FY2025 · AG · contact PI
VoiceLove: An App-Based COMmunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)$1,306,077
R42 · FY2025 · AG · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2025 · VA · contact PI
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD$5,665,215
R01 · FY2024 · AG · contact PI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study$3,155,165
R01 · FY2024 · AG · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2024 · VA · contact PI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study$3,532,548
R01 · FY2023 · AG · contact PI
VoiceLove: An App-Based COMmunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)$506,500
R42 · FY2023 · AG · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2023 · VA · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2022 · VA · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2022 · VA · contact PI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study$3,630,964
R01 · FY2021 · AG · contact PI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study$3,470,697
R01 · FY2020 · AG · contact PI
BRAIN-2 COVID-19 Administrative Supplement$868,245
R01 · FY2020 · AG · contact PI
BRAIN-2 Administrative Supplement with ORCHID-BUD$424,619
R01 · FY2020 · AG · contact PI
Returning to Everyday Tasks Utilizing Rehabilitation Networks-III Pilot Randomized Clinical Trial (RETURN-III Pilot RCT)$0
I01 · FY2020 · VA · contact PI
BRAIN-ICU-2 Study: Bringing to Light the Risk Factors And Incidence of Neuropsychological Dysfunction (Dementia) in ICU Survivors, 2nd Study$3,262,056
R01 · FY2019 · AG · contact PI
The MIND USA Study$971,918
R01 · FY2016 · AG · contact PI
The MIND USA Study$186,499
R01 · FY2016 · AG · contact PI
The MIND USA Study$1,550,166
R01 · FY2015 · AG · contact PI
The MIND USA Study$1,528,602
R01 · FY2014 · AG · contact PI
The MIND USA Study$41,867
R01 · FY2014 · AG · contact PI
The MIND USA Study$1,550,454
R01 · FY2012 · AG · contact PI
The MIND USA Study$1,519,086
R01 · FY2011 · AG · contact PI
The MIND ICU Study$591,365
R01 · FY2010 · AG · contact PI
The MIND ICU Study$57,350
R01 · FY2010 · AG · contact PI
The MIND ICU Study$593,417
R01 · FY2009 · AG · contact PI
The MIND ICU Study$596,943
R01 · FY2008 · AG · contact PI
The MIND ICU Study$603,172
R01 · FY2007 · AG · contact PI
CORE--PATIENT SUPPORT$36,827
U54 · FY2007 · HL · contact PI
The MIND ICU Study$603,311
R01 · FY2006 · AG · contact PI
CORE--PATIENT SUPPORT$30,655
U54 · FY2006 · HL · contact PI
Cognitive Impairment in the ICU: Evaluation and Outcomes$124,443
K23 · FY2005 · AG
Cognitive Impairment in the ICU: Evaluation and Outcomes$124,443
K23 · FY2004 · AG
Cognitive Impairment in the ICU: Evaluation and Outcomes$124,035
K23 · FY2003 · AG
Cognitive Impairment in the ICU: Evaluation and Outcomes$124,035
K23 · FY2002 · AG
Cognitive Impairment in the ICU: Evaluation and Outcomes$123,899
K23 · FY2001 · AG